Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
3xw86K7bnpxqnt7c
